If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
28.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (7.407%)
Market Cap: £13.34m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Holding in Company

5 Sep 2016 12:00

RNS Number : 9609I
Pennant International Group PLC
05 September 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

PENNANT INTERNATIONAL GROUP PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

X

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation: iii

HARGREAVE HALE LIMITED

4. Full name of shareholder(s) (if different from 3.):iv

DISCRETIONARY CLIENTS

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

02 SEPTEMBER 2016

6. Date on which issuer notified:

05 SEPTEMBER 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

14% and 13%

      
 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Indirect

Direct xi

Indirect xii

Direct

Indirect

GB0002570660

4,186,636

4,186,636

 

4,186,636

 

4,186,636

 

12.7085%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

4,186,636

12.7085%

               
 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

All of these shares are held for unit trusts operated by Marlborough Fund Managers Ltd, for whom Hargreave Hale Ltd manages the investments on a discretionary basis.

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will ceaseto hold:

 

12. Date on which proxy holder will cease to holdvoting rights:

 

 

13. Additional information:

The change in the percentage of shares held is due entirely to the placing by Pennant International Group Plc, the shares from which were admitted to AIM on 02/09/2016.

14. Contact name:

David Clueit,

Hargreave Hale Ltd

15. Contact telephone number:

01253 754739

   

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBGGDCUSGBGLU
Date   Source Headline
24th Jun 20267:00 amRNS-RFirst Auxilium – GenS Sale via Siemens Partnership
12th Jun 20267:00 amRNSMultiyear Auxilium Services Contract Award
4th Jun 20267:00 amRNS-RLaunch of Auxilium Phase 3
20th May 20263:18 pmRNSHolding(s) in Company
19th May 20267:20 amRNS-R1st conversion services contract & Siemens update
14th May 20267:00 amRNSDirector dealing
13th May 20267:00 amRNSGrant of Options
11th May 20267:00 amRNSTraining Systems Contract Win
8th May 202611:56 amRNSResult of AGM
21st Apr 20262:05 pmRNSHolding(s) in Company
1st Apr 20262:54 pmRNSNotice of AGM & Posting of Accounts
31st Mar 20265:00 pmRNSTotal Voting Rights
26th Mar 20267:00 amRNSIssue of Equity
23rd Mar 20267:00 amRNSFinal Results & Notice of Investor Presentation
2nd Feb 20267:00 amRNSTraining Systems Contract Win
19th Jan 20267:00 amRNSTrading & Strategy Update, Notice of Results
15th Jan 20267:00 amRNSDirectorate change
12th Dec 20253:34 pmRNSDirector Dealing
1st Dec 20251:36 pmRNSDirector Dealing
27th Nov 20259:40 amRNSHolding(s) in Company
25th Nov 202512:40 pmRNSGenFly Contract Award - valued at up to £5.75m
24th Oct 202511:15 amRNSHolding(s) in Company
21st Oct 20257:00 amRNSShareholder Loan
8th Oct 202510:36 amRNSContract wins
1st Oct 20259:39 amRNSTotal Voting Rights
25th Sep 202512:59 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSSubscription update and closing & TVR
16th Sep 20257:01 amRNSProposed Underwritten Subscription to raise £1.25m
16th Sep 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
14th Aug 20257:00 amRNSChange of Adviser
11th Aug 20253:01 pmRNSHolding(s) in Company
8th Aug 20257:00 amRNSTrading Update & Notice of Results
14th Jul 20257:00 amRNSGlobal Partner Appointed & Auxilium Presentation
3rd Jul 20257:00 amRNSBusiness Update
6th Jun 20251:08 pmRNSResult of AGM
8th May 202512:30 pmRNSNotice of AGM & Posting of Accounts
24th Apr 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
9th Apr 20257:00 amRNSGenFly Contract Update
8th Apr 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
7th Apr 20257:00 amRNSProperty Disposal Programme Update
11th Mar 20252:25 pmRNSHolding(s) in Company
24th Feb 20257:00 amRNSProperty Disposal Programme Update
3rd Feb 20251:41 pmRNSDirector Dealings
16th Dec 202410:49 amRNSHolding(s) in Company
12th Dec 20247:00 amRNSAward of Options
10th Dec 20247:00 amRNSTrading Statement, Business Update & Investor Pres
20th Nov 20247:00 amRNSAppointment of CFO
14th Nov 20242:47 pmRNSHolding(s) in Company
6th Nov 20244:34 pmRNSHolding(s) in Company
23rd Oct 20243:56 pmRNSContracts Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.